Cargando…
Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008184/ https://www.ncbi.nlm.nih.gov/pubmed/36918143 http://dx.doi.org/10.1016/j.cmi.2023.03.010 |
| _version_ | 1784905700584980480 |
|---|---|
| author | Rawson, Timothy M. Moore, Luke S.P. |
| author_facet | Rawson, Timothy M. Moore, Luke S.P. |
| author_sort | Rawson, Timothy M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10008184 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100081842023-03-13 Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design Rawson, Timothy M. Moore, Luke S.P. Clin Microbiol Infect Commentary European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2023-06 2023-03-12 /pmc/articles/PMC10008184/ /pubmed/36918143 http://dx.doi.org/10.1016/j.cmi.2023.03.010 Text en © 2023 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Commentary Rawson, Timothy M. Moore, Luke S.P. Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title | Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title_full | Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title_fullStr | Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title_full_unstemmed | Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title_short | Understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| title_sort | understanding how diagnostics influence antimicrobial decision-making is key to successful clinical trial design |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008184/ https://www.ncbi.nlm.nih.gov/pubmed/36918143 http://dx.doi.org/10.1016/j.cmi.2023.03.010 |
| work_keys_str_mv | AT rawsontimothym understandinghowdiagnosticsinfluenceantimicrobialdecisionmakingiskeytosuccessfulclinicaltrialdesign AT moorelukesp understandinghowdiagnosticsinfluenceantimicrobialdecisionmakingiskeytosuccessfulclinicaltrialdesign |